Intravitreal Gene Therapy for Wet AMD

Video

An overview of new gene therapy options for wet AMD that are currently being explored in clinical trials.

Related Videos
George Tachas, PhD
Alexandra Gomez-Arteaga, MD
Pietro Genovese, PhD, the principal investigator at the Gene Therapy Program of Dana-Farber/Boston Children’s Cancer and Blood Disorder Center
Akshay Sharma, MBBS, a bone marrow transplant physician at St. Jude Children’s Research Hospital
M. Peter Marinkovich, MD, on Bringing RDEB Treatment to the Local Level
Caspian Oliai, MD, MS, the medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center
Frederick “Eric” Arnold, PhD
Genovefa (Zenia) Papanicolaou, MD, an infectious diseases specialist at Memorial Sloan Kettering Cancer Center
Jeffrey Chamberlain, PhD, on Exciting New Research at MDA 2024
Alan Beggs, PhD, on Challenges in Therapeutic Development for Rare Diseases
Related Content
GenSight Biologics’ LHON Gene Therapy Lumevoq Continues to Show Efficacy and Safety 4 Years Out

GenSight Biologics’ LHON Gene Therapy Lumevoq Continues to Show Efficacy and Safety 4 Years Out

April 22nd 2024
Article

The results come from the randomized, double-masked, placebo-controlled phase 3 REFLECT clinical trial (NCT03293524).

CGTLive®’s Weekly Rewind – April 19, 2024

CGTLive®’s Weekly Rewind – April 19, 2024

April 19th 2024
Article

Review top news and interview highlights from the week ending April 19, 2024.

Arshad M. Khanani, MD, MA, FASRS, Director of Clinical Research, Sierra Eye Associates and Clinical Professor, Reno School of Medicine, University of Nevada

MCO-010 Phase 2b Data Supports BLA Submission for Retinitis Pigmentosa

April 19th 2024
Article

Nanoscope Therapeutics received feedback from the FDA endorsing significant change in BCVA as a primary endpoint supporting approval.

Nancy J. Newman, MD

Gene Therapy Improves Vision Recovery in LHON Over Idebenone, Natural History

April 18th 2024
Article

Data from a meta-analysis of 3 groups of patients were presented at AAN 2024.

Around the Helix: Cell and Gene Therapy Company Updates – April 17, 2024

Around the Helix: Cell and Gene Therapy Company Updates – April 17, 2024

April 17th 2024
Article

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Jeffrey S. Heier, MD

RGX-314 Reduces nAMD Treatment Burden, Shows Disease Improvements

April 12th 2024
Article

One participant experienced a possibly related serious AE of pigmentary changes in the macula with severe vision reduction.

© 2024 MJH Life Sciences

All rights reserved.